PRMT5 activates lipid metabolic reprogramming via MYC contributing to the growth and survival of mantle cell lymphoma.
Liang JH, Wang WT, Wang R, Gao R, Du KX, Duan ZW, Zhang XY, Li Y, Wu JZ, Yin H, Shen HR, Wang L, Li JY, Guo JR, Xu W.
Liang JH, et al. Among authors: wang wt.
Cancer Lett. 2024 Jun 1;591:216877. doi: 10.1016/j.canlet.2024.216877. Epub 2024 Apr 13.
Cancer Lett. 2024.
PMID: 38615930